US Stock MarketDetailed Quotes

RDHL Redhill Biopharma

Watchlist
  • 0.450
  • -0.001-0.16%
Close May 3 16:00 ET
  • 0.458
  • +0.008+1.80%
Post 17:46 ET
14.33MMarket Cap0.11P/E (TTM)

Redhill Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.73%-35.82M
36.14%-10.59M
-72.95%-7.19M
55.13%-29.19M
83.71%-2.42M
68.32%-6.03M
12.26%-16.58M
66.13%-4.16M
-33.90%-65.05M
-16.95%-14.86M
Net income from continuing operations
133.37%23.92M
106.50%761K
344.74%50.24M
26.68%-71.67M
84.70%-3.73M
-66.93%-35.7M
59.79%-11.71M
10.21%-20.53M
-28.32%-97.74M
-0.17%-24.37M
Operating gains losses
-277.57%-47.21M
-196.62%-5.08M
-24,950.00%-994K
-10,265.85%-12.5M
-17,909.30%-7.66M
-18,547.06%-3.14M
-10,182.35%-1.71M
-91.30%4K
21.78%123K
-83.52%43K
Depreciation and amortization
-75.59%1.99M
-3,174.11%-58.9M
2,729.05%60.49M
-55.07%8.15M
-82.06%2.01M
-10.64%2.09M
-16.51%1.92M
-7.81%2.14M
107.54%18.15M
338.94%11.19M
Other non cash items
-101.64%-543K
20,436.13%63.04M
-3,936.63%-119.82M
517.80%33.15M
146.02%1.58M
3,209.67%28.76M
-125.47%-310K
18.34%3.12M
-11.04%5.37M
-73.02%641K
Change In working capital
-295.04%-15.62M
-106.56%-11.11M
-68.69%2.76M
794.54%8.01M
200.28%4.24M
111.19%342K
-478.87%-5.38M
86.72%8.8M
-113.69%-1.15M
-179.38%-4.23M
-Change in receivables
1,222.32%31.93M
150.52%3.95M
381.75%27.67M
5.83%-2.85M
190.55%1.49M
-3,732.26%-2.25M
-15.15%-7.82M
7.37%5.74M
88.99%-3.02M
89.90%-1.64M
-Change in inventory
-37.20%2.39M
-229.77%-3.31M
857.25%5.15M
145.88%3.8M
192.87%1.58M
80.12%-865K
403.55%2.55M
119.61%538K
-78.40%-8.29M
-18.93%-1.7M
-Change in prepaid assets
478.83%1.59M
195.26%2.12M
-167.85%-783K
-68.14%274K
-5,323.81%-1.1M
-28.46%-501K
460.80%718K
-19.19%1.15M
126.24%860K
102.37%21K
-Change in payables and accrued expense
-37.81%-14.31M
-21.44%-4.29M
-65.95%-7.38M
-237.59%-10.38M
-16.26%-3.8M
319.81%1.4M
-178.71%-3.53M
-21.65%-4.44M
-111.52%-3.08M
-147.54%-3.27M
-Change in other working capital
-316.89%-37.22M
-454.79%-9.58M
-476.92%-21.9M
38.74%17.16M
158.39%6.09M
13.36%2.56M
-20.98%2.7M
34.08%5.81M
-27.57%12.37M
-86.14%2.36M
Cash from discontinued investing activities
Operating cash flow
-22.73%-35.82M
36.14%-10.59M
-72.95%-7.19M
55.13%-29.19M
83.71%-2.42M
68.32%-6.03M
12.26%-16.58M
66.13%-4.16M
-33.90%-65.05M
-16.95%-14.86M
Investing cash flow
Cash flow from continuing investing activities
-99.95%4K
95.71%-7K
0
201.99%8.3M
0
99.74%-22K
95.35%-163K
2,093.02%8.49M
77.17%-8.14M
-55.46%3.5M
Net PPE purchase and sale
94.44%-11K
95.71%-7K
--0
-72.17%-198K
--0
-4.76%-22K
-5,333.33%-163K
85.23%-13K
71.67%-115K
93.88%-3K
Net investment purchase and sale
-99.82%15K
--0
--0
205.92%8.5M
--0
--0
--0
1,689.47%8.5M
-144.28%-8.03M
-55.70%3.5M
Cash from discontinued investing activities
Investing cash flow
-99.95%4K
95.71%-7K
--0
201.99%8.3M
--0
99.74%-22K
95.35%-163K
2,093.02%8.49M
77.17%-8.14M
-55.46%3.5M
Financing cash flow
Cash flow from continuing financing activities
87.19%21.44M
-99.98%3K
197.29%4.81M
-84.41%11.45M
-59.02%7.2M
-472.67%-5.72M
943.24%14.92M
-108.43%-4.94M
-12.93%73.46M
121.25%17.57M
Net issuance payments of debt
20.34%-1.18M
17.46%-293K
-157.39%-296K
12.36%-1.48M
15.42%-384K
-40.50%-621K
11.69%-355K
69.97%-115K
-102.20%-1.68M
-7.08%-454K
Net common stock issuance
-41.36%13.96M
-110.39%-1.61M
840.81%6.71M
-69.69%23.81M
-61.74%7.59M
--0
5,580.59%15.51M
-98.77%713K
229.06%78.54M
136.92%19.82M
Proceeds from stock option exercised by employees
--0
----
----
--0
--0
--0
--0
----
7,603.85%4.01M
--0
Net other financing activities
179.56%8.66M
908.05%1.91M
71.09%-1.6M
-47.06%-10.88M
--0
-196.34%-5.1M
86.55%-236K
-160.80%-5.54M
53.77%-7.4M
---1.8M
Cash from discontinued financing activities
Financing cash flow
87.19%21.44M
-99.98%3K
197.29%4.81M
-84.41%11.45M
-59.02%7.2M
-472.67%-5.72M
943.24%14.92M
-108.43%-4.94M
-12.93%73.46M
121.25%17.57M
Net cash flow
Beginning cash position
-32.25%19.97M
-39.09%17.57M
-32.25%19.97M
0.61%29.47M
-34.62%15.2M
-47.92%26.99M
-62.03%28.85M
0.61%29.47M
0.94%29.3M
-11.24%23.25M
Current changes in cash
-52.46%-14.38M
-479.80%-10.59M
-288.24%-2.38M
-3,529.09%-9.43M
-23.04%4.78M
58.76%-11.77M
92.44%-1.83M
-101.31%-612K
93.66%275K
101.13%6.21M
Effect of exchange rate changes
71.05%-22K
156.25%18K
-40.00%-21K
20.83%-76K
-277.78%-16K
23.53%-13K
-328.57%-32K
85.44%-15K
-173.85%-96K
0.00%9K
End cash Position
-72.11%5.57M
-74.08%7M
-39.09%17.57M
-32.25%19.97M
-32.25%19.97M
-34.62%15.2M
-47.92%26.99M
-62.03%28.85M
0.61%29.47M
0.61%29.47M
Free cash flow
-21.94%-35.83M
36.72%-10.6M
-72.41%-7.19M
54.91%-29.38M
83.71%-2.42M
68.23%-6.05M
11.41%-16.74M
66.26%-4.17M
36.34%-65.16M
-16.53%-14.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.73%-35.82M36.14%-10.59M-72.95%-7.19M55.13%-29.19M83.71%-2.42M68.32%-6.03M12.26%-16.58M66.13%-4.16M-33.90%-65.05M-16.95%-14.86M
Net income from continuing operations 133.37%23.92M106.50%761K344.74%50.24M26.68%-71.67M84.70%-3.73M-66.93%-35.7M59.79%-11.71M10.21%-20.53M-28.32%-97.74M-0.17%-24.37M
Operating gains losses -277.57%-47.21M-196.62%-5.08M-24,950.00%-994K-10,265.85%-12.5M-17,909.30%-7.66M-18,547.06%-3.14M-10,182.35%-1.71M-91.30%4K21.78%123K-83.52%43K
Depreciation and amortization -75.59%1.99M-3,174.11%-58.9M2,729.05%60.49M-55.07%8.15M-82.06%2.01M-10.64%2.09M-16.51%1.92M-7.81%2.14M107.54%18.15M338.94%11.19M
Other non cash items -101.64%-543K20,436.13%63.04M-3,936.63%-119.82M517.80%33.15M146.02%1.58M3,209.67%28.76M-125.47%-310K18.34%3.12M-11.04%5.37M-73.02%641K
Change In working capital -295.04%-15.62M-106.56%-11.11M-68.69%2.76M794.54%8.01M200.28%4.24M111.19%342K-478.87%-5.38M86.72%8.8M-113.69%-1.15M-179.38%-4.23M
-Change in receivables 1,222.32%31.93M150.52%3.95M381.75%27.67M5.83%-2.85M190.55%1.49M-3,732.26%-2.25M-15.15%-7.82M7.37%5.74M88.99%-3.02M89.90%-1.64M
-Change in inventory -37.20%2.39M-229.77%-3.31M857.25%5.15M145.88%3.8M192.87%1.58M80.12%-865K403.55%2.55M119.61%538K-78.40%-8.29M-18.93%-1.7M
-Change in prepaid assets 478.83%1.59M195.26%2.12M-167.85%-783K-68.14%274K-5,323.81%-1.1M-28.46%-501K460.80%718K-19.19%1.15M126.24%860K102.37%21K
-Change in payables and accrued expense -37.81%-14.31M-21.44%-4.29M-65.95%-7.38M-237.59%-10.38M-16.26%-3.8M319.81%1.4M-178.71%-3.53M-21.65%-4.44M-111.52%-3.08M-147.54%-3.27M
-Change in other working capital -316.89%-37.22M-454.79%-9.58M-476.92%-21.9M38.74%17.16M158.39%6.09M13.36%2.56M-20.98%2.7M34.08%5.81M-27.57%12.37M-86.14%2.36M
Cash from discontinued investing activities
Operating cash flow -22.73%-35.82M36.14%-10.59M-72.95%-7.19M55.13%-29.19M83.71%-2.42M68.32%-6.03M12.26%-16.58M66.13%-4.16M-33.90%-65.05M-16.95%-14.86M
Investing cash flow
Cash flow from continuing investing activities -99.95%4K95.71%-7K0201.99%8.3M099.74%-22K95.35%-163K2,093.02%8.49M77.17%-8.14M-55.46%3.5M
Net PPE purchase and sale 94.44%-11K95.71%-7K--0-72.17%-198K--0-4.76%-22K-5,333.33%-163K85.23%-13K71.67%-115K93.88%-3K
Net investment purchase and sale -99.82%15K--0--0205.92%8.5M--0--0--01,689.47%8.5M-144.28%-8.03M-55.70%3.5M
Cash from discontinued investing activities
Investing cash flow -99.95%4K95.71%-7K--0201.99%8.3M--099.74%-22K95.35%-163K2,093.02%8.49M77.17%-8.14M-55.46%3.5M
Financing cash flow
Cash flow from continuing financing activities 87.19%21.44M-99.98%3K197.29%4.81M-84.41%11.45M-59.02%7.2M-472.67%-5.72M943.24%14.92M-108.43%-4.94M-12.93%73.46M121.25%17.57M
Net issuance payments of debt 20.34%-1.18M17.46%-293K-157.39%-296K12.36%-1.48M15.42%-384K-40.50%-621K11.69%-355K69.97%-115K-102.20%-1.68M-7.08%-454K
Net common stock issuance -41.36%13.96M-110.39%-1.61M840.81%6.71M-69.69%23.81M-61.74%7.59M--05,580.59%15.51M-98.77%713K229.06%78.54M136.92%19.82M
Proceeds from stock option exercised by employees --0----------0--0--0--0----7,603.85%4.01M--0
Net other financing activities 179.56%8.66M908.05%1.91M71.09%-1.6M-47.06%-10.88M--0-196.34%-5.1M86.55%-236K-160.80%-5.54M53.77%-7.4M---1.8M
Cash from discontinued financing activities
Financing cash flow 87.19%21.44M-99.98%3K197.29%4.81M-84.41%11.45M-59.02%7.2M-472.67%-5.72M943.24%14.92M-108.43%-4.94M-12.93%73.46M121.25%17.57M
Net cash flow
Beginning cash position -32.25%19.97M-39.09%17.57M-32.25%19.97M0.61%29.47M-34.62%15.2M-47.92%26.99M-62.03%28.85M0.61%29.47M0.94%29.3M-11.24%23.25M
Current changes in cash -52.46%-14.38M-479.80%-10.59M-288.24%-2.38M-3,529.09%-9.43M-23.04%4.78M58.76%-11.77M92.44%-1.83M-101.31%-612K93.66%275K101.13%6.21M
Effect of exchange rate changes 71.05%-22K156.25%18K-40.00%-21K20.83%-76K-277.78%-16K23.53%-13K-328.57%-32K85.44%-15K-173.85%-96K0.00%9K
End cash Position -72.11%5.57M-74.08%7M-39.09%17.57M-32.25%19.97M-32.25%19.97M-34.62%15.2M-47.92%26.99M-62.03%28.85M0.61%29.47M0.61%29.47M
Free cash flow -21.94%-35.83M36.72%-10.6M-72.41%-7.19M54.91%-29.38M83.71%-2.42M68.23%-6.05M11.41%-16.74M66.26%-4.17M36.34%-65.16M-16.53%-14.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg